Table VIII.
The DEGs co-expressed with differentially expressed lncRNAs associated with pathways in cancer.
| lncRNA/pathway | DEG |
|---|---|
| lnc-SCD-1:13 | |
| Wnt signaling pathway | DVL1, FZD7, NFAT5, WNT11, WNT7B |
| Hedgehog signaling pathway | BMP4, WNT11, WNT7B |
| Basal cell carcinoma | BMP4, DVL1, FZD7, WNT11, WNT7B |
| ECM-receptor interaction | HSPG2, ITGA3, ITGB4, LAMA3, SDC1 |
| Glycolysis/gluconeogenesis | ALDH1A3, ALDOA, PKM |
| Aldosterone-regulated sodium reabsorption | ATP1A1, SFN, SGK1 |
| Glycerolipid metabolism | AGPAT2, AKR1B1, LIPG |
| Metabolism of xenobiotics by cytochrome P450 | AKR1C2, ALDH1A3, CYP1B1 |
| Steroid hormone biosynthesis | AKR1C2, CYP1B1, SULT2B1 |
| Epithelial cell signaling in H. pylori infection | ATP6AP1, CXCL8, MAP3K14 |
| Pathways in cancer | BMP4, CXCL8, DVL1, FOS, FZD7, ITGA3, LAMA3, WNT11, WNT7B |
| Arrhythmogenic right ventricular cardiomyopathy | ITGA3, ITGB4, PKP2 |
| Melanogenesis | DVL1, FZD7, WNT11, WNT7B |
| lnc-LRR1-1:2 | |
| Wnt signaling pathway | DVL1, NFAT5, WNT11, WNT7B |
| Axon guidance | EFNA3, NFAT5, RHOD, UNC5B |
| ECM-receptor interaction | ITGA3, LAMA3, SDC1 |
| Basal cell carcinoma | BMP4, DVL1, WNT11, WNT7B |
| Aldosterone-regulated sodium reabsorption | ATP1A1, SGK1 |
| Hedgehog signaling pathway | BMP4, WNT11, WNT7B |
| Malaria | CXCL8, SDC1 |
| Glycerolipid metabolism | AGPAT2, AKR1B1 |
| T cell receptor signaling pathway | FOS, MAP3K14, NFAT5 |
| Pathways in cancer | BMP4, CXCL8, DVL1, FOS, ITGA3, LAMA3, SLC2A1, WNT11, WNT7B |
| Melanogenesis | DVL1, WNT11, WNT7B |
| Protein digestion and absorption | ATP1A1, KCNE3, SLC1A5 |
| lnc-PTMS-1:3 | |
| Basal cell carcinoma | BMP4, DVL1, WNT11, WNT7B |
| Aldosterone-regulated sodium reabsorption | SFN, SGK1 |
| Hedgehog signaling pathway | BMP4, WNT11, WNT7B |
| ECM-receptor interaction | ITGA3, LAMA3, SDC1 |
| Pathways in cancer | BMP4, DVL1, FOS, ITGA3, LAMA3, SLC2A1, WNT11, WNT7B |
| Melanogenesis | DVL1, WNT11, WNT7B |
| lnc-S100P-3:1 | |
| ECM-receptor interaction | ITGA3, LAMA3, SDC1 |
| Basal cell carcinoma | BMP4, DVL1, WNT11, WNT7B |
| Glycolysis/gluconeogenesis | ACSS2, ALDH1A3, ALDOA, ENO2 |
| Aldosterone-regulated sodium reabsorption | ATP1A1, SFN, SGK1 |
| Hedgehog signaling pathway | BMP4, WNT11, WNT7B |
| Metabolism of xenobiotics by cytochrome P450 | AKR1C2, ALDH1A3, CYP1B1 |
| Steroid hormone biosynthesis | AKR1C2, CYP1B1, SULT2B1 |
| Pathways in cancer | BMP4, CXCL8, DVL1, FOS, ITGA3, LAMA3, SLC2A1, WNT11, WNT7B |
| Fructose and mannose metabolism | AKR1B1, ALDOA |
| Protein digestion and absorption | ATP1A1, KCNE3, SLC1A5 |
| lnc-AP000974.1-1:1 | |
| Wnt signaling pathway | DVL1, FZD7, NFAT5, WNT11, WNT7B |
| Hedgehog signaling pathway | BMP4, WNT11, WNT7B |
| Basal cell carcinoma | BMP4, DVL1, FZD7, WNT11, WNT7B |
| ECM-receptor interaction | HSPG2, ITGA3, ITGB4, LAMA3, SDC1 |
| Glycolysis/gluconeogenesis | ALDH1A3, ALDOA, ENO2, PKM |
| Aldosterone-regulated sodium reabsorption | ATP1A1, SFN, SGK1 |
| Glycerolipid metabolism | AGPAT2, AKR1B1, LIPG |
| Metabolism of xenobiotics by cytochrome P450 | AKR1C2, ALDH1A3, CYP1B1 |
| Steroid hormone biosynthesis | AKR1C2, CYP1B1, SULT2B1 |
| Pathways in cancer | BMP4, CXCL8, DVL1, FOS, FZD7, ITGA3, LAMA3, WNT11, WNT7B |
| Arrhythmogenic right ventricular cardiomyopathy | ITGA3, ITGB4, PKP2 |
| Melanogenesis | DVL1, FZD7, WNT11, WNT7B |
| lnc-RAB3IL1-2:1 | |
| Axon guidance | NFAT5, SEMA7A, UNC5B |
| Basal cell carcinoma | DVL1, FZD7 |
| Extracellular matrix-receptor interaction | HSPG2, ITGA3, ITGA6 |
| Aldosterone-regulated sodium reabsorption | ATP1A1, SGK1 |
| Folate biosynthesis | ALPP, ALPPL2 |
| Glycerolipid metabolism | AGPAT2, LIPG |
| N-Glycan biosynthesis | MGAT3, ST6GAL1 |
| Regulation of actin cytoskeleton | FGD3, ITGA3, ITGA6, PFN1 |
| Pathways in cancer | CXCL8, DVL1, FZD7, ITGA3, ITGA6 |
| Arrhythmogenic right ventricular cardiomyopathy | ITGA3, ITGA6, PKP2 |
lncRNA, long non-coding ribonucleic acid; DEGs, differentially expressed genes.